Uummmm. You mean like that Alzheimers stock? It fell below the $1 per share split adjusted price earlier today even on the vaunted Nasdaq.
Looking at some of the recent Psoriosis drug deals there are almost certainly interested parties. Unless one buys into the theory that information will leak ahead of that announcement, then that deal could indeed catch many off guard. The CEO has indicated he is open to deals on Prurisol, so that's half the battle.
News 
Market Data 
Discover 
AI
